Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need. The Company has a world-class scientific advisory team including recognized global experts... Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need. The Company has a world-class scientific advisory team including recognized global experts in pulmonary hypertension. The Company owns North American rights to develop and commercialize levosimendan and has recently released topline data regarding their Phase 2 clinical trial for the use of levosimendan in the treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction (PH-HFpEF). For more information, visit www.tenaxthera.com. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.21 | -3.58974358974 | 5.85 | 6.01 | 5.39 | 20914 | 5.57212447 | CS |
4 | 0.62 | 12.3505976096 | 5.02 | 7.2 | 5.02 | 62485 | 5.81510446 | CS |
12 | 2.17 | 62.5360230548 | 3.47 | 7.2 | 3.25 | 64493 | 4.93190814 | CS |
26 | 2.87 | 103.610108303 | 2.77 | 7.2 | 2.77 | 281884 | 3.89804179 | CS |
52 | -19.128 | -77.2286821705 | 24.768 | 27.3272 | 2.77 | 263073 | 7.38280189 | CS |
156 | -1770.36 | -99.6824324324 | 1776 | 2335.04 | 2.77 | 1608607 | 111.31276735 | CS |
260 | -1850.36 | -99.6961206897 | 1856 | 5888 | 2.77 | 1384478 | 1025.62462586 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관